The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for A Natarajan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.EBI
University of Nebraska Medical Center
Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases.EBI
University of Nebraska Medical Center
Exploiting the P-1 pocket of BRCT domains toward a structure guided inhibitor design.EBI
TBA
Structure-activity relationship studies to probe the phosphoprotein binding site on the carboxy terminal domains of the breast cancer susceptibility gene 1.EBI
University of Nebraska Medical Center
Synthesis and screening of 3-substituted thioxanthen-9-one-10,10-dioxides.EBI
University of Texas Medical Branch
CitA activity is modulated by cysteine oxidation and pyruvate binding.EBI
University of Nebraska
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.EBI
Eppley Institute For Cancer Research
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax.EBI
University of Nebraska Medical Center
Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy.EBI
Eppley Institute For Research In Cancer and Allied Diseases
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.EBI
Institute For Research In Cancer and Allied Diseases